|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.155 EUR | +6.16% |
|
-15.16% | +35.96% |
| Apr. 11 | Nanoform Finland to Deliver Nanomedicine Technology to Japan | MT |
| Apr. 11 | Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan | CI |
Nanoform Finland Oyj reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 2.57 million compared to EUR 3.49 million a year ago. Net loss was EUR 20.76 million compared to EUR 22.08 million a year ago.
Basic loss per share from continuing operations was EUR 0.26 compared to EUR 0.29 a year ago. Diluted loss per share from continuing operations was EUR 0.26 compared to EUR 0.29 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.96% | 197M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
NANOFORM FINLAND OYJ 
